Aligning Science Across Parkinson’s (ASAP) is a coordinated research initiative to accelerate discoveries for Parkinson’s disease. We are managed by the Coalition for Aligning Science (CAS) and work collaboratively with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to implement our programs. The initiative was incubated under Dr. Ekemini Riley’s leadership with support from the Sergey Brin Family Foundation.
Executive Leadership
Managing Director
Ekemini A. U. Riley, PhD
Aligning Science Across Parkinson's (ASAP) | Coalition for Aligning Science (CAS) | USA
Deputy Director
Sonya Dumanis, PhD
Aligning Science Across Parkinson's (ASAP) | Coalition for Aligning Science (CAS) | USA
Implementation Partner
Since ASAP’s inception, The Michael J. Fox Foundation (MJFF) has worked in parallel with ASAP to complement its programs. We leverage the MJFF grantmaking and scientific infrastructure to process proposals, issue grants, and steward key scientific teams.
Current Scientific Advisory Board
Randy Schekman, PhD
Chair of the Scientific Advisory Board, University of California at Berkeley & Howard Hughes Medical Institute | USA
“Parkinson’s Disease presents a challenging scientific problem as well as a major unmet medical need. The ASAP Initiative offers an opportunity for major innovative impact on both fronts in this important area.”
Planning Advisory Council
With thanks to ASAP’s founding Advisory Council for their input and guidance in development of the strategic roadmap.
James Beck, PhD
Chief Scientific Officer, VP, Scientific Affairs, Parkinson’s Foundation
Patrik Brundin, MD, PhD
Van Andel Research Institute Center for Neurodegenerative Science
Pietro De Camilli, MD
Kavli Institute for Neuroscience at Yale School of Medicine
Marie-Françoise Chesselet, MD, PhD
Van Andel Institute Center for Neurodegenerative Science
Martin Citron, PhD
UCB Pharma
David Dexter, PhD
Parkinson’s UK, Imperial College London
Ted Dawson MD, PhD
Johns Hopkins University School of Medicine
Thomas Gasser, MD, PhD
Hertie Institute for Clinical Brain Research
Magali Haas, MD, PhD
Cohen Veterans Bioscience
Karl Kieburtz, MD, MPH
University of Rochester Medical Center
Walter Koroshetz, MD
National Institute of Neurological Disease and Stroke
Robert Malenka, MD, PhD
Stanford University School of Medicine
Kelsey Martin, MD, PhD
David Geffen School of Medicine at UCLA
Eliezer Masliah, MD
National Institute of Aging, NIH
K. Kimberly McCleary
The Kith Collective
Karoly Nikolich, PhD
Alkahest
C. Warren Olanow, MD
Mt. Sinai School of Medicine
Bernardo Sabatini, MD, PhD
Harvard Medical School
Randy Schekman, PhD
University of California, Berkeley
Darryle Schoepp, PhD
Merck
Todd Sherer, PhD
The Michael J. Fox Foundation for Parkinson’s Research
Andrew Singleton, PhD
Global Parkinson’s Genetics Program (GP2)
Beth Stevens, PhD
Harvard Medical School
David Sulzer, PhD
Columbia University Medical Center
Huda Zoghbi, MD
Baylor College of Medicine
